Evidence map›Paper›PMID 35027730›Full record

ArticleNature cell biology2022

53BP1-shieldin-dependent DSB processing in BRCA1-deficient cells requires CST-Polα-primase fill-in synthesis.

Zachary Mirman, Nanda Kumar Sasi, Ashleigh King, J Ross Chapman, Titia de Lange

Open access · greenAbstract read
In one paragraph

Article in Nature cell biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Mechanisms and disease relevance of DNA break repair pathway choice.Nature reviews. Molecular cell biology · 2026
    Review
  3. Article
  4. Science advances · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Zachary MirmanLaboratory for Cell Biology and Genetics, Rockefeller University, New York, NY, USA.ORCID http://orcid.org/0000-0002-5832-285X
Nanda Kumar SasiLaboratory for Cell Biology and Genetics, Rockefeller University, New York, NY, USA.
Ashleigh KingMedical Research Council (MRC) Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
J Ross ChapmanMedical Research Council (MRC) Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-6477-4254
Titia de LangeLaboratory for Cell Biology and Genetics, Rockefeller University, New York, NY, USA. delange@rockefeller.edu.ORCID http://orcid.org/0000-0002-9267-367X
Rockefeller University · USUniversity of Oxford · GB

Funding

Genome instability in cancer: telomeres and DNA repairR35CA210036 · NCI · ROCKEFELLER UNIVERSITY · PI Titia de Lange · 2016 to 2026
$10.8M
Genome Integrity Through the Cell Cycle in Homeostasis and CancerK00CA245720 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI MIRMAN, ZACHARY KENNETH · 2022 to 2025
$397k
Genome Integrity Through the Cell Cycle in Homeostasis and CancerF99CA245720 · NCI · ROCKEFELLER UNIVERSITY · PI MIRMAN, ZACHARY KENNETH · 2019 to 2020
$92k
Cancer Research UK 19270Cancer Research UK C52690/A19270Medical Research Council MC_UU_00016/19Medical Research Council MR/R017549/1NCI NIH HHS F99 CA245720NCI NIH HHS K00 CA245720NCI NIH HHS R35 CA210036
6 · The paper itself

Abstract

The efficacy of poly(ADP)-ribose polymerase 1 inhibition (PARPi) in BRCA1-deficient cells depends on 53BP1 and shieldin, which have been proposed to limit single-stranded DNA at double-strand breaks (DSBs) by blocking resection and/or through CST-Polα-primase-mediated fill-in. We show that primase (like 53BP1-shieldin and CST-Polα) promotes radial chromosome formation in PARPi-treated BRCA1-deficient cells and demonstrate shieldin-CST-Polα-primase-dependent incorporation of BrdU at DSBs. In the absence of 53BP1 or shieldin, radial formation in BRCA1-deficient cells was restored by the tethering of CST near DSBs, arguing that in this context, shieldin acts primarily by recruiting CST. Furthermore, a SHLD1 mutant defective in CST binding (SHLD1Δ) was non-functional in BRCA1-deficient cells and its function was restored after reconnecting SHLD1Δ to CST. Interestingly, at dysfunctional telomeres and at DNA breaks in class switch recombination where CST has been implicated, SHLD1Δ was fully functional, perhaps because these DNA ends carry CST recognition sites that afford SHLD1-independent binding of CST. These data establish that in BRCA1-deficient cells, CST-Polα-primase is the major effector of shieldin-dependent DSB processing.

Indexed as

DNA Breaks, Double-StrandedAnimalsBinding SitesBRCA1 ProteinCell Line, TumorCRISPR-Cas SystemsDNADNA Polymerase IDNA PrimaseDNA RepairGene Knockout TechniquesHumansMicePoly(ADP-ribose) Polymerase InhibitorsPoly(ADP-ribose) PolymerasesRad51 RecombinaseBRCA1 ProteinBRCA1 protein, humanCtc1 protein, humanDNADNA Polymerase IDNA PrimasePoly(ADP-ribose) Polymerase InhibitorsPoly(ADP-ribose) PolymerasesRAD51 protein, humanRad51 RecombinaseShelterin ComplexTelomere-Binding ProteinsTP53BP1 protein, humanTumor Suppressor p53-Binding Protein 1

Identifiers

PMID35027730
PMCPMC8849574
OpenAlexW4206497350

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.